TrialBMC cancer2020

Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced oesophageal squamous cell carcinoma: a single-Centre, open-label, randomized, controlled, clinical trial (HCHTOG1903).

Hai-Bo Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.